Harmonic Bionics
Harmonic Bionics developed the Harmony SHR, a bilateral upper extremity robotic exoskeleton for neurorehabilitation. It sold capital equipment to rehabilitation hospitals, clinics, and university research programs across the US and select international markets before being acquired by Bioness Medical in June 2025.
- Company typePrivate
- Founded2016
- HeadquartersAustin, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Harmonic Bionics does
Harmonic Bionics is a commercial-stage rehabilitation robotics company that developed, registered, and commercialized the Harmony SHR, a bilateral upper extremity robotic exoskeleton for neurorehabilitation. The Harmony SHR architecture is differentiated by a shoulder design that replicates the glenohumeral joint and includes a scapular component to facilitate scapulohumeral rhythm, supporting approximately 85% of the shoulder's natural range of motion. The platform integrates Bilateral Sync mode for robotic-assisted mirror therapy, integrated motion and effort sensing for objective joint-angle and force assessment, motorized sizing, weight support for earlier post-stroke intervention, and the proprietary EsmaCAT high-speed mechatronics and software platform released as a separate product. Multiple granted US patents protect the actuators, compliant sensing mechanism, electronic boards, and mechanical exoskeleton architecture, with a registered Harmony SHR trademark.
The company monetizes primarily through capital-equipment sales of the Harmony SHR to enterprise rehabilitation hospitals, clinics, and university research programs, supplemented by professional services for training and ongoing support. Pricing is opaque and quote-based; the company uses consultative field sales backed by customized ROI modeling, live virtual demonstrations, in-person demonstrations at rehab facilities, and a heavy conference presence (APTA CSM, AOTA Inspire, ACRM, AAPM&R, LSI Emerging Medtech Summit). Domestic direct sales are complemented by an international channel-partner network covering Hong Kong and Macau (Healthlink Holdings), Qatar (Intermodal Services Co.), Vietnam (BaoNam Co.), and South Korea (Curexo Inc.). Named reference customers include Barrow Neurological Institute (Dignity Health, the first US clinical installation, two systems), Brooks Rehabilitation, CUHK Medical Centre (the first international installation), St. David's Rehabilitation Hospital, and research placements at the University of Houston REIGN Lab and Auburn University WeBR Lab.
Harmonic Bionics was founded in 2016 in Austin, Texas by Dr. Ashish Deshpande and Dr. Youngmok Yun out of research at the University of Texas at Austin, following NSF I-Corps customer discovery work. The leadership team combines academic founders with commercial executives including CEO Christopher Prentice (ex-Mazor Robotics and Medtronic), CFO Chris White, and CCO/Strategy Officer Gusty Denis. The company raised approximately $13-14M across an NSF SBIR Phase 1 grant ($250K in 2018), a $2.45M early-round in 2020, a $7M Series A led by KNet Investment Partners and Big Basin Capital in May 2021, and a $3M strategic investment from Curexo Inc. in May 2022. FDA registered Harmony SHR as a Class II 510(k)-exempt device in April 2023, achieved first US clinical installation in October 2023, first international installation in May 2024, and was acquired by Bioness Medical on June 18, 2025 to expand Bioness's neuro-rehabilitation portfolio. Bioness Medical itself had been acquired by Accelmed Partners on December 31, 2024.
Harmonic Bionics firmographics
Firmographics- Name
- Harmonic Bionics
- Legal name
- Harmonic Bionics, Inc.
- Website
- https://harmonicbionics.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- Harmonic Bionics developed the Harmony SHR, a bilateral upper extremity robotic exoskeleton for neurorehabilitation. It sold capital equipment to rehabilitation hospitals, clinics, and university research programs across the US and select international markets before being acquired by Bioness Medical in June 2025.
- Ownership category
- akta.pro rank
Harmonic Bionics industry classification
Industry- Product category
- Rehabilitation Robotics
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Healthcare & Assistive Robotics (HDAAAIAC)
- akta.pro secondary industries
- Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG), Orthotics & Bracing (Spinal/Lower/Upper Extremity Orthoses) (HLAHAEAI), Hand & Upper Extremity Therapy (OT/CHT) (HSADAIAH), Corrective Exercise, Movement Screening & Biomechanics (HSADAIAM)
Keywords
Where Harmonic Bionics is headquartered
LocationHeadquarters
- HQ city
- Austin
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Harmonic Bionics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Revenue model
- Harmony SHR Hardware Sales: Sale of the Harmony SHR bilateral upper extremity robotic rehabilitation exoskeleton system to rehabilitation hospitals, clinics, and healthcare facilities. Hardware device sold as a capital equipment purchase. Post-sale support and service likely bundled or available as separate professional services.
- Professional Services (Training & Support): Training, in-service demonstrations, and ongoing support services for rehabilitation facilities deploying Harmony SHR. Contact form for customized ROI models for hospitals or facilities.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | — | Harmony SHR Robotic Rehabilitation System |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels7 records
Harmonic Bionics product offering
Product offeringCore offering
Harmonic Bionics develops and sells the Harmony SHR, a bilateral upper extremity robotic rehabilitation exoskeleton used by physical and occupational therapists to treat patients recovering from stroke, spinal cord injury, traumatic brain injury, and other neurological or musculoskeletal movement impairments. The system combines a biomechanically matched shoulder design (mimicking scapulohumeral rhythm) with bilateral sync mirror therapy, motorized sizing, and integrated motion/effort sensors to deliver objective, data-driven therapy. The company also offers EsmaCAT, a standalone high-speed mechatronics and software platform for robotic systems.
Product overview
Harmonic Bionics is a commercial-stage robotics company offering a focused product portfolio centered on its flagship Harmony SHR bilateral upper extremity robotic rehabilitation system. Harmony SHR works with a patient's scapulohumeral rhythm to enable natural, comprehensive arm and shoulder therapy for those with neurological and musculoskeletal movement impairments. The company also offers the EsmaCAT mechatronics and software platform as a standalone product. The ecosystem includes therapy applications, patient attachments, and assessment capabilities. The company was acquired by Bioness Medical in June 2025 to expand Bioness's neuro rehabilitation portfolio.
Differentiator
Problem solved
Functional benefit
Brands
- Harmony SHR: A bilateral upper extremity robotic rehabilitation system that works with a patient's scapulohumeral rhythm (SHR) to enable natural, comprehensive arm and shoulder therapy for those living with neurological and musculoskeletal movement impairments.
Products and services
- Harmony SHR Bilateral upper extremity robotic rehabilitation exoskeleton system that works with a patient's scapulohumeral rhythm to enable natural, comprehensive arm and shoulder therapy for patients recovering from stroke, spinal cord injury, traumatic brain injury, and other neurological or musculoskeletal movement impairments. Sold as capital equipment to rehabilitation hospitals, clinics, and research institutions.
- EsmaCAT Mechatronics and Software Platform High-speed mechatronics and software platform released as a standalone product, enabling high-speed communication between multiple actuators and a master controller for robotic systems.
Quantifiable outcome
- Patients achieved 20 degree increase in shoulder abduction range of motion and 10 degree increase in shoulder flexion after less than 4 weeks of Harmony SHR therapy — their largest gains in over a year (patient Bob Kuhn, Brooks Rehabilitation)
- +3 more outcomes
Companies that use Harmonic Bionics
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles2 records
Harmonic Bionics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Harmonic Bionics partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered primary, core and minor.
- Healthlink Holdings LTDprimaryExclusive distributor agreement for Hong Kong and Macau territories. Healthlink Holdings, established in 2008, focuses on innovative medical, rehabilitation and sport science equipment. The company has over 30 years of experience marketing pharmaceutical, medical, and rehabilitation products and represents many world-renowned manufacturers. Sales Director Samuel Chan noted stroke incidence in Hong Kong increased over 50% in the prior ten years.
- Curexo Inc.coreStrategic partnership with South Korea-based Curexo Inc. includes a $3 million investment and agreement for Harmonic Bionics to assist with US promotion and business development for Curexo’s Morning Walk S200 robotic gait rehabilitation system and CUVIS-spine surgical robot. Curexo listed on Korean Stock Exchange with Morning Walk S200 in use at 23 hospitals in South Korea. The partnership was extended in April 2024 for Curexo to distribute Harmony SHR in South Korea.
- H Robotics Inc.minorPartnership to assist with US distribution of rebless™, an FDA-registered smart rehabilitation device for upper and lower limbs (elbow, wrist, ankle, knee). rebless received a CES 2021 Innovation Award in the Health and Wellness category. Controlled through a smartphone app with telemedicine and clinic management software. H Robotics CEO is Dr. Ig-Mo Koo.
- Intermodal Services Co. W.L.L.minorDistributor for Qatar, located at Building 69, Suite 201, B-Ring Road, Doha. Tel: +974 4462 1168.
- BaoNam Co., LTDminorDistributor for Vietnam, located at House No. 12, Lane 198, Thai Ha Street, Trung Liet Ward, Dong Da District, Hanoi City, Vietnam.
- University of Houston REIGN LabminorDr. Jinsook Roh’s lab (2022 NSF CAREER award recipient) purchased Harmony SHR for research on neural mechanisms of motor coordination and motor impairment quantification in stroke patients. Provides clinical feedback and research validation.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Harmonic Bionics competitors and assessment
Company assessmentDirect peers
- Tyromotion: Tyromotion (Austria) makes the Diego, Pablo, and Amadeo upper-extremity rehabilitation robotic and mechatronic devices. Like Harmonic Bionics, it sells into neurological and orthopedic rehab clinics and competes for the same therapy budget and Class II capital equipment slots.
- Myomo: Myomo makes the MyoPro powered upper-extremity orthosis for stroke and neurological patients. It is a direct competitor in the upper-extremity rehab and assistance category with overlapping clinical use cases (stroke, neurological injury) and similar hospital/patient buyers.
- Hocoma (DIH Medical): Hocoma, now part of DIH Medical, is the established leader in upper-extremity robotic rehabilitation with the Armeo product family (ArmeoPower, ArmeoSpring, ArmeoSenso). It is the most direct competitor to Harmony SHR globally and shares the same customer base of inpatient and outpatient rehabilitation hospitals.
- Fourier Intelligence: Fourier Intelligence (China) makes the ArmMotus EMU and similar upper-extremity rehab robots, plus lower-extremity RehabHub devices. It is a direct competitor targeting the same hospital, clinic, and international distributor accounts as Harmonic Bionics.
- Saebo: Saebo is a US-based vendor of upper-extremity rehabilitation devices (SaeboFlex, SaeboReach, SaeboStim). It competes for the same occupational therapy and stroke rehab budgets, although its products are mechanical/electrical orthoses rather than full robotic exoskeletons.
Broad incumbents
- ReWalk Robotics: ReWalk Robotics is a publicly listed exoskeleton company focused primarily on lower-extremity personal and rehab devices (ReWalk Personal 6.0). It is a broad incumbent in the medical exoskeleton category and shares the same hospital and rehabilitation buyer universe as Harmonic Bionics.
- Ekso Bionics: Ekso Bionics is a publicly listed wearable exoskeleton company best known for the EksoGT lower-extremity gait rehab device, with broader exposure in industrial and medical robotics. It is a broad incumbent in rehabilitation robotics with overlapping hospital buyers but a different anatomical focus.
Others
- Bioness Medical: Bioness Medical is the strategic acquirer of Harmonic Bionics (June 2025) and now the parent company. It sells the L300 Go (FES) and other neuro-rehab products, so it is now the commercial platform through which Harmony SHR reaches customers, making it both a corporate parent and an adjacent rehab portfolio company.
Emerging players
- BioXtreme: BioXtreme is a startup developing the BioXtreme upper-extremity robotic rehabilitation system for shoulder and arm therapy in neurological patients. It is an emerging player with partial overlap in product category and target use case (post-stroke upper-limb rehab), although it remains at an earlier commercialization stage.
- Aretech (ZeroG): Aretech makes the ZeroG bodyweight-support and gait rehab system for neurological and orthopedic rehabilitation. It is an emerging player with partial overlap in the rehab robotics category, sharing the same inpatient rehab hospital buyers but focused on lower-extremity and balance therapy.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Harmonic Bionics social profiles
Digital presenceHarmonic Bionics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Harmonic Bionics leadership team
Management profileNumber of profiles
Profiles5 records
Harmonic Bionics funding detail
Funding detailFunding overview
Funding rounds5 records
Investors12 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Harmonic Bionics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Harmonic Bionics
What does Harmonic Bionics do?
Harmonic Bionics develops and sells the Harmony SHR, a bilateral upper extremity robotic rehabilitation exoskeleton used by physical and occupational therapists to treat patients recovering from stroke, spinal cord injury, traumatic brain injury, and other neurological or musculoskeletal movement impairments. The system combines a biomechanically matched shoulder design (mimicking scapulohumeral rhythm) with bilateral sync mirror therapy, motorized sizing, and integrated motion/effort sensors to deliver objective, data-driven therapy. The company also offers EsmaCAT, a standalone high-speed mechatronics and software platform for robotic systems.
Is Harmonic Bionics a public or private company?
Harmonic Bionics is a private company. It is classified as venture growth investor backed and is currently acquired.
When was Harmonic Bionics founded?
Harmonic Bionics was founded in 2016. It employs 11 to 50 people.
Where is Harmonic Bionics based?
Harmonic Bionics is headquartered in Austin, United States, in the North America region.
How does Harmonic Bionics make money?
Two revenue lines are on record. Harmony SHR Hardware Sales are the primary driver. The others are professional Services (Training & Support).
Who are Harmonic Bionics's main competitors?
Direct peers on record are Tyromotion, Myomo, Hocoma (DIH Medical), Fourier Intelligence and Saebo. Broad incumbents are ReWalk Robotics and Ekso Bionics. Bioness Medical is listed as an others. Emerging players are BioXtreme and Aretech (ZeroG).
Does Harmonic Bionics have an API?
No public API is recorded for Harmonic Bionics.
What industry is Harmonic Bionics in?
Harmonic Bionics's product category is Rehabilitation Robotics. Its primary akta.pro industry code is HDAAAIAC, Healthcare & Assistive Robotics, with a secondary code of HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices). Its NAICS code is 334510 and its SIC code is 3842.